142 related articles for article (PubMed ID: 7756475)
1. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.
Carratalá J; Fernández-Sevilla A; Tubau F; Callis M; Gudiol F
Clin Infect Dis; 1995 Mar; 20(3):557-60; discussion 561-3. PubMed ID: 7756475
[TBL] [Abstract][Full Text] [Related]
2. Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.
Krcmery V; Spanik S; Mrazova M; Trupl J; Grausova S; Grey E; Kukuckova E; Sulcova M; Krupova I; Koren P
Int J Infect Dis; 2002 Mar; 6(1):69-73. PubMed ID: 12044306
[TBL] [Abstract][Full Text] [Related]
3. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.
Aparicio JR; Such J; Pascual S; Arroyo A; Plazas J; Girona E; Gutiérrez A; de Vera F; Palazón JM; Carnicer F; Pérez-Mateo M
J Hepatol; 1999 Aug; 31(2):277-83. PubMed ID: 10453941
[TBL] [Abstract][Full Text] [Related]
4. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections.
Peña C; Albareda JM; Pallares R; Pujol M; Tubau F; Ariza J
Antimicrob Agents Chemother; 1995 Feb; 39(2):520-4. PubMed ID: 7726525
[TBL] [Abstract][Full Text] [Related]
5. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea.
Cheong HJ; Yoo CW; Sohn JW; Kim WJ; Kim MJ; Park SC
Clin Infect Dis; 2001 Jul; 33(1):48-53. PubMed ID: 11389494
[TBL] [Abstract][Full Text] [Related]
6. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
7. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
[TBL] [Abstract][Full Text] [Related]
8. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
Rangaraj G; Granwehr BP; Jiang Y; Hachem R; Raad I
Cancer; 2010 Feb; 116(4):967-73. PubMed ID: 20052728
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Aoki T; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2014; 9(1):e85210. PubMed ID: 24465506
[TBL] [Abstract][Full Text] [Related]
10. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.
Carratalá J; Alcaide F; Fernández-Sevilla A; Corbella X; Lińares J; Gudiol F
Clin Infect Dis; 1995 May; 20(5):1169-73. PubMed ID: 7619995
[TBL] [Abstract][Full Text] [Related]
11. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J
Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975
[TBL] [Abstract][Full Text] [Related]
12. Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan.
Zaidi Y; Hastings M; Murray J; Hassan R; Kurshid M; Mahendra P
Clin Lab Haematol; 2001 Feb; 23(1):39-42. PubMed ID: 11422229
[TBL] [Abstract][Full Text] [Related]
13. Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis.
Cereto F; Molina I; González A; Del Valle O; Esteban R; Guardia J; Genescà J
Aliment Pharmacol Ther; 2003 Mar; 17(5):695-701. PubMed ID: 12641519
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea.
Yoo JH; Huh DH; Choi JH; Shin WS; Kang MW; Kim CC; Kim DJ
Clin Infect Dis; 1997 Dec; 25(6):1385-91. PubMed ID: 9431383
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
[TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.
Carratala J; Fernandez-Sevilla A; Tubau F; Dominguez MA; Gudiol F
Antimicrob Agents Chemother; 1996 Feb; 40(2):503-5. PubMed ID: 8834911
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution.
González-Barca E; Fernández-Sevilla A; Carratalá J; Grañena A; Gudiol F
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):291-6. PubMed ID: 8781879
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
20. Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.
Kern WV; Markus A; Andriof E
Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):161-5. PubMed ID: 8013490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
